MatriSys Bioscience Finds $1.5M From Tech Coast Angels

San Diego-based MatriSys Bioscience, which is developing treatments for treating skin and dermatologic conditions, says it has raised $1.5M in a funding round from the Tech Coast Angels. The lead investor in the investment was Jeff Friedman, MD, Ph.D., who is head of the TCA's Life Sciences Committee. The company's technology is based on skin microbiome research developed at the University of San Diego, in the labs of Professor Richard Gallo. The company said it developing live biological therapeutics (LBTs) that rebalance the normal mix of bacterial species present on the skin. Mark S. Wilson is CEO of MatriSys.